Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mosaic Capital Partners is a private equity investment firm focused on employee-ownership buyouts rather than a therapeutics, biotech, pharma, or healthcare operating business. The firm was founded in 2013 and is headquartered in Charlotte, North Carolina. Mosaic acquires lower middle market companies through Employee Stock Ownership Plan (ESOP) or Employee Ownership Trust (EOT) transactions and positions itself as an employee ownership-focused private equity firm. Its portfolio spans multiple industries, including some exposure to healthcare and life sciences-adjacent businesses, but Mosaic itself does not appear to develop drugs, devices, or clinical-stage products. For biotech analyst purposes, this entity is best classified as a financial sponsor/investor rather than a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mosaic Capital Partners.